US Stock MarketDetailed Quotes

GALT Galectin Therapeutics

Watchlist
  • 2.840
  • -0.240-7.79%
Close May 14 16:00 ET
  • 2.920
  • +0.080+2.82%
Post 16:39 ET
175.81MMarket Cap-3837P/E (TTM)

Galectin Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Galectin Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.16

+11.11%
Analyst Rating

Buy

Apr 1, 2024

Galectin Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Galectin Therapeutics Earnings Reports

  • Galectin Therapeutics | 10-K: Annual report

    Mar 29 07:56 ET

  • Galectin Therapeutics: Q3 2023 Earnings Report

    Nov 13, 2023 07:50 ET

  • Galectin Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 14, 2023 07:51 ET

  • Galectin Therapeutics | 10-Q: Q1 2023 Earnings Report

    May 15, 2023 07:50 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 1, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg